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MaMitral annulus calciﬁcation (MAC) is a chronic, degenerative process in the ﬁbrous base of the mitral valve. Although MAC
was initially thought to be an age-related degenerative process, there is accumulating evidence that other mechanisms,
such as atherosclerosis and abnormal calcium-phosphorus metabolism, also contribute to the development of MAC.
Despite its frequency, the clinical relevance of MAC is grossly underappreciated. Indeed, MAC is associated with an
increased incidence of cardiovascular disease, mitral valve disease, arrhythmias, and mortality. MAC also inﬂuences the
outcomes of cardiac surgery and interventions, and its clinical relevance may well increase substantially in the forth-
coming era of transcatheter mitral valve replacement. In this paper, we review the available published data to provide a
consistent, clinically relevant description of MAC on the basis of contemporary imaging. We describe the pathophysio-
logical mechanisms contributing to the formation of MAC and the clinical implications of this disease entity.
(J Am Coll Cardiol 2015;66:1934–41) © 2015 by the American College of Cardiology Foundation.M itral annulus calciﬁcation (MAC) is achronic, degenerative process of theﬁbrous support structure of the mitral
valve (1,2). The reported prevalence of MAC is be-
tween 8% and 15%, but it signiﬁcantly increases
with age and in patients with multiple cardiovascular
risk factors or chronic kidney disease (CKD) (3–7).
Although calciﬁcation of the mitral annulus was
initially thought to be an age-related process, there
is accumulating evidence that it is a tightly regulated,
active process, with features similar to both medial
and atherosclerotic cardiovascular calciﬁcation (8).
Its clinical relevance comes from MAC’s association
with an increased rate of mortality and cardiovascular
disease (CVD) (9). MAC has also been found to in-
crease the incidence of mitral valve disease and
arrhythmias and to inﬂuence the outcome of car-
diac surgery (2,10,11). We reviewed the available pub-
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ing; 2) a ﬁrm understanding of its pathogenesis and
associations; and 3) the clinical implications of this
disease entity.
DEFINITION AND DIAGNOSIS
The mitral annulus separates the left atrium from the
left ventricle (LV). It has a complex saddle shape that
is divided into anterior and posterior portions. The
anterior annulus spans the left and right ﬁbrous
trigones and is anatomically coupled to the aortic
annulus. The posterior annulus encompasses the
remainder of the annular perimeter and is composed
of a discontinuous rim of ﬁbrous tissue periodically
interrupted by fat (12). MAC is deﬁned as a chronic
degenerative process in the ﬁbrous base of the mitral
valve (1,2,13). In 1910, Dewitzky recognized nonin-
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AB BR EV I A T I O N S
AND ACRONYM S
AF = atrial ﬁbrillation
CAD = coronary artery disease
CKD = chronic kidney disease
CT = computed tomography
CVD = cardiovascular disease
LV = left ventricle/ventricular
MAC = mitral annulus
calciﬁcation
MR = mitral regurgitation
= mitral valve prolapse
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1935ﬁbrosus as an entity, presented a detailed patholog-
ical description of 36 cases, and likened the lesion to a
similar process in the aortic valve described by
Mönckeberg in 1904 (1). Large historical autopsy
studies found MAC in approximately 10% of patients
(3,14). MAC more commonly affects the posterior
annulus than the anterior annulus (15,16).
Occasionally, a chest x-ray might reveal calciﬁc
demarcation of the mitral annulus. MAC is usually
seen as a C-, J-, U- or O-shape, with the open part
lying at the site of the aortic outﬂow tract (2). Lateral
projection usually better demonstrates mitral calciﬁ-
cation because the overlying spine and main left
lower lobe arteries in the posteroanterior view may
mask its visualization. Fluoroscopy during coronary
angiography can also show mitral calciﬁcation, but is
not an accurate modality for assessment of the extent
of MAC.
Previously, echocardiography was considered to be
the best method to demonstrate MAC (17). MAC can
be recognized by M-mode echocardiography as an
echo-dense band beneath the posterior mitral leaﬂet,
with motion paralleling that of the free ventricular
wall (2). The 2-dimensional technique more clearly
demonstrates the localization of MAC to the angle
between the LV posterior wall and the posterior
mitral leaﬂet (18). MAC is usually visualized as an
echo-dense, shelf-like structure with an irregular,
lumpy appearance involving the mitral valve
annulus, with associated acoustic shadowing. In a
subanalysis of the Framingham Heart Study, MAC
was assessed by M-mode echocardiography and
deﬁned as an echo-dense band visualized throughout
systole and diastole, distinguishable from the poste-
rior mitral valve leaﬂet, and located anterior and
parallel to the posterior LV wall (9). In the Cardio-
vascular Health Study, MAC was deﬁned by an
intense echocardiograph-producing structure located
at the junction of the atrioventricular groove and
posterior mitral leaﬂet (19). Severity was qualitatively
determined in parasternal short-axis view at the level
of the mitral annulus as mild (focal, limited increase
in echodensity of the mitral annulus), moderate
(marked echodensity involving one-third to one-half
of the ring circumference), or severe (marked echo-
density involving more than one-half of the circum-
ference of the ring or with intrusion into the
LV inﬂow tract). Maximal MAC thickness measured
from the anterior to the posterior edge at its greatest
width is also used to assess MAC severity, with a
value >4 mm deﬁning severe MAC (20).
It has been suggested that echocardiography is
probably not an ideal method for detection of
valvular calciﬁcation because of its relatively lowspeciﬁcity in distinguishing between calciﬁ-
cation and dense collagen (5). Electron-beam
computed tomography (CT) and multislice
(spiral) CT are effective, noninvasive tech-
niques for cardiac, coronary, and aortic
calciﬁcation imaging (4,21). Cardiac CT is a
useful tool to predict the extent and location
of MAC (22) and to quantify MAC objectively
in order to assess the severity and associa-
tions of this entity (23). Allison et al. (4)
assessed CT scans of 1,242 subjects without
known coronary artery disease (CAD) (4).
MAC was deﬁned as calciﬁcation located at
the junction between the left atrium and LV. Quan-
tiﬁcation of MAC with sufﬁcient reproducibility can
also be performed using the Agatston method with
calculation of calciﬁcation in every level of the mitral
annulus (23). Examples of the various diagnostic
modalities in a patient with MAC are presented in
Figure 1.
PATHOGENESIS AND ASSOCIATIONS
The pathophysiological mechanisms contributing to
the formation of MAC are not fully understood. Pre-
vious autopsy histological and clinicopathological
studies have shed light on the pathogenesis of MAC.
Large, contemporary imaging studies that examined
the association between MAC and other disease en-
tities, such as atherosclerosis and CKD, have further
enhanced our knowledge and enabled a better un-
derstanding of this process and its clinical importance
(Central Illustration). Although MAC was ﬁrst consid-
ered a passive, degenerative, age-related process
(1,13), accumulating evidence now points toward a
tightly regulated process with features similar to both
medial and atherosclerotic cardiovascular calciﬁca-
tion (8). A comprehensive description of the patho-
genesis and associations of MAC can be found in the
Online Appendix.
A DEGENERATIVE, AGE-RELATED PROCESS. Sell
et al. (13) described calciﬁcation of the mitral annulus
as a chronic, age-related, degenerative, noninﬂam-
matory process in the ﬁbrous support structure of the
mitral valve. Kanjanauthai et al. (5) evaluated 6,814
CT scans of participants enrolled in MESA (Multi-
Ethnic Study of Atherosclerosis). The overall preva-
lence of MAC was 9%, and multivariable analysis
found increased age to be independently associated
with MAC in all ethnicities.
ATHEROSCLEROSIS. On the basis of pathological
features seen in specimens from more than 300 pa-
tients with MAC (e.g., ﬁnding foam cells in early
mitral annular lesions) and the strong association
MVP
FIGURE 1 Diagnosis of MAC
A 76-year-old female patient presented for evaluation of severe aortic stenosis.
(A) Fluoroscopy before selective injection to the right coronary artery in the left
anterior oblique projection showing heavily calciﬁed mitral annulus (black
arrows). (B) Transthoracic echocardiography in parasternal short-axis view,
demonstrating calciﬁcation of the posterior mitral annulus (white arrows). The
maximal MAC thickness (L) is 1.22 cm. (C) Cardiac computed tomography with
double oblique view at the mitral annular level, demonstrating C-shaped severe
MAC (white arrows). There is also calciﬁcation in the left ventricular outﬂowtract
and the aortic valve (black arrows). MAC ¼mitral annulus calciﬁcation.
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1936between the coexistence of MAC and cardiovascular
risk factors, Roberts (24) suggested that MAC and
vascular atherosclerosis are different forms of the
same disease.
Many studies have shown a strong association
between MAC and cardiovascular risk factors (5,17,25).
A strong correlation was also demonstrated between
MAC and aortic atheroma, carotid atherosclerotic
disease, peripheral artery disease, and CAD (17,19).
These studies further support the hypothesis that
calciﬁcation of the mitral annulus is strongly asso-
ciated with the pathogenesis of atherosclerosis.
CONDITIONS WITH INCREASED MITRAL VALVE
STRESS. Degenerative calciﬁcation of the mitral
annular area is accelerated by conditions that in-
crease mitral valve stress: hypertension, aortic ste-
nosis, and hypertrophic cardiomyopathy (2,15,26). In
these conditions, LV peak systolic pressure (and
therefore mitral valve closing pressure) is increased,
resulting in excess annular tension and subsequent
annulus degeneration. Elmariah et al. (27) found
recent support for this association by demonstrating a
strong correlation between LV hypertrophy and the
prevalence, severity, and incidence of MAC. Calciﬁ-
cation of the mitral annulus is also associated with
the excess tension encountered in disorders of mitral
valve motion: mitral valve prolapse (MVP) and mitral
valve replacement (2,16,28,29).
ABNORMAL CALCIUM-PHOSPHORUS METABOLISM.
MAC is a common ﬁnding in patients with CKD.
This association may be partially explained by an
increased prevalence and severity of cardiovascular
risk factors and atherosclerotic disease in these
patients (30). Nonetheless, there is growing evidence
that the abnormal calcium-phosphorus metabolism
observed in patients with chronic renal failure has a
direct role in the pathogenesis of MAC (2,26,31).
CONGENITAL METABOLIC DISORDERS ASSOCIATED
WITH MAC. Marfan syndrome. In the past, MAC
at <40 years of age was considered a minor diagnostic
criterion for Marfan syndrome (32). Aortic root dila-
tion and MVP are common cardiovascular features of
this disease (33). It remains unclear whether the mitral
annulus calciﬁes because of increased mitral stress
caused by MVP or due to an intrinsic abnormality of
the connective tissue composing the annulus.
Hur ler syndrome. Calciﬁcation of the mitral
annulus has been reported in children with Hurler
syndrome (34). Abnormal ﬁbroblasts and accelerated
collagen degeneration may cause the early appear-
ance of MAC in these patients (2).
SEX-RELATED DIFFERENCES. Contrary to the ath-
erosclerosis paradigm, several studies have found
CENTRAL ILLUSTRATION Mitral Annulus Calciﬁcation Overview: Diagnosis, Risk Factors, and Clinical Implications
DIAGNOSTIC IMAGING
• Echocardiography:
MAC is visualized as an 
echodense structure
with an irregular, lumpy 
appearance and an 
associated acoustic 
shadowing.
• Computed tomography: 
Highly effective for 
cardiac, coronary, and 
aortic calcification 
imaging. A useful tool to 
evaluate the extent and 
location of MAC.
RISK FACTORS FOR MAC
• Increased age
• Female
• Chronic kidney disease
• Multiple cardiovascular risk factors 
(hypertension, diabetes mellitus, 
dyslipidemia, smoking)
• Increased MV stress 
(hypertension, aortic stenosis, 
hypertrophic cardiomyopathy, 
MV prolapse)
• Metabolic disorders 
(Marfan syndrome, Hurler syndrome)
• Osteoporosis
CLINICAL IMPLICATIONS
• Increase in cardiovascular 
disease and mortality 
• Increase in MV disease 
(mitral regurgitation, 
mitral stenosis, 
endocarditis)
• Increase in arrhythmias 
(conduction system 
disease, atrial fibrillation)
• Increase in MV surgery 
complications and 
mortality
MITRAL VALVE CALCIFICATION
Definition: chronic degenerative process 
in the fibrous base of the MV, more 
commonly in the posterior annulus
than the anterior annulus
Mitral
valve
Calcification
on posterior
annulus
Anterior
annulus
Abramowitz, Y. et al. J Am Coll Cardiol. 2015; 66(17):1934–41.
Histological, clinicopathological, and contemporary imaging studies that examined the association between mitral annulus calciﬁcation and other disease
entities enhanced our knowledge of the pathogenesis of MAC and enabled a better understanding of this process and its clinical importance. MAC ¼ mitral
annulus calciﬁcation; MV ¼ mitral valve.
TABLE 1 Summary of the Clinical Implications of MAC
Cardiovascular disease
[ Cardiovascular events (9,42)
[ Cardiovascular mortality (9,41,43)
[ CAD (44)
[ Stroke (47,48)
Mitral valve disease
[ Mitral regurgitation (2,38,52)
[ Mitral stenosis (only with severe MAC) (1,52)
[ Endocarditis (39,53,54)
Arrhythmias
[ Conduction system disease (AVB, BBB) (2,39,40)
[ Atrial ﬁbrillation (11,57)
Cardiac surgery and interventions
[ Complications following mitral valve surgery (10,16)
[ Intraoperative conversion from mitral valve repair to
replacement (29)
[ PPM implantation and YMR improvement following TAVR (61,62)
[ ¼ increase in; Y ¼ decrease in; AVB ¼ atrioventricular block; BBB ¼ bundle
branch block; CAD ¼ coronary artery disease; MAC ¼ mitral annulus calciﬁcation;
MR ¼ mitral regurgitation; PPM ¼ permanent pacemaker; TAVR ¼ transcatheter
aortic valve replacement.
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1937that female sex is associated with an increased risk of
developing MAC (5,25,35). On the basis of his sys-
tematic pathological evaluation of 200 patients with
MAC, Roberts (36) concluded that larger deposits are
more frequent in women, although MAC of any de-
gree appears to occur with similar frequency in men
and women. It has been suggested that MAC in
elderly women can be attributed to ectopic calcium
deposits related to the severe bone loss caused by
post-menopausal osteoporosis (37).
CLINICAL IMPLICATIONS
MAC is usually an incidental ﬁnding in patients being
evaluated for cardiovascular or pulmonary diseases.
The presence of a calciﬁed mitral annulus is asymp-
tomatic, which precludes true evaluation of the
prevalence of MAC in the general population. In
large historical autopsy studies, MAC was found in
approximately 10% of patients (3,14). CT scans
or echocardiography assessments of MAC without
deﬁning its severity revealed calciﬁcation in 8% to
15% of patients without known CVD (4,5,7,9). The
prevalence of MAC was 42% in elderly patients with
known CVD (19).
Several clinical implications have been associated
with MAC, including CVD, mitral valve disease, and
arrhythmias (2,9,11,19,38–40) (Table 1). When severe,MAC also has implications for the complexity of
mitral valve operations (10,16).
MAC AND CARDIOVASCULAR RISK. As discussed
earlier, MAC is associated with cardiovascular risk
factors as well as with CKD and osteoporosis. There is
growing evidence that identiﬁcation of a calciﬁed
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1938mitral annulus can also be related independently to a
higher risk of cardiovascular events and mortality
(9,19,41–43). Fox et al. (9) examined the association
between MAC and CVD among 1,197 subjects over 16
years of follow-up in the Framingham Heart Study. In
multivariable adjustment for traditional cardiovas-
cular risk factors, MAC was associated with an
increased risk of incident CVD (hazard ratio [HR]: 1.5;
95% conﬁdence interval [CI]: 1.1 to 2.0), cardiovas-
cular death (HR: 1.6; 95% CI: 1.1 to 2.3), and all-cause
death (HR: 1.3; 95% CI: 1.04 to 1.6). Interestingly, Atar
et al. (44) found that MAC is associated with an
increased prevalence of severe obstructive CAD.
Possible explanations for these ﬁndings are that MAC
may be a marker for atherosclerotic disease burden or
that other unmeasured factors, such as metabolic,
inﬂammatory, and hemostatic risk factors, might be
responsible for the increased risk of CVD and mor-
tality in patients with MAC (9,17).
There are inconsistent ﬁndings with respect to the
association between MAC and the risk for clinical
stroke (45–49). Rodriguez et al. (49) found that MAC is
associated with increased risk for brain infarcts, but
this association diminished after adjustments for po-
tential confounders. However, Kizer et al. (48) found
that the presence of MAC is a strong risk factor for
stroke after adjustments for other predictors. Possible
explanations for the association between MAC and
clinical strokemay derive from the increased incidence
of carotid atherosclerotic disease, aortic atheroma, and
atrial ﬁbrillation (AF) among patients withMAC (11,17),
or from direct embolization of mobile calciﬁed annular
components that may cause brain infarcts (50).
MAC AND MITRAL VALVE DISEASE. MAC generally
has little or no effect on LV inﬂow or mitral valve
function because, unlike in rheumatic mitral involve-
ment, there is usual sparing of the leaﬂet commissures
in these patients (2). Nonetheless, severe calciﬁcation
of the mitral annulus may occasionally cause mitral
regurgitation (MR) or mitral stenosis (2,38,51,52).
There is limited evidence that MAC is associated
with an increased risk of MR and that it may exacer-
bate MR in some cases (2,38,52). Movahed et al. (38)
examined 24,380 echocardiograms and found MAC
to be present in 11.7% of patients with MR versus 4.3%
without MR. A possible mechanism for this associa-
tion is that calcium inﬁltration of the base of the
posterior leaﬂet reduces leaﬂet mobility, increases
traction on the chordae, and elevates the leaﬂets.
This facilitates chordal elongation or rupture, causing
secondary MR. An alternative mechanism is failure
of the calciﬁed annulus to contract at the end of
diastole (52).Mitral stenosis due to annular calciﬁcation is re-
ported to be quite rare (2). Nonetheless, it was
demonstrated that severe MAC could produce a sig-
niﬁcant resting gradient across the mitral valve, thus
causing mitral stenosis (1,52). This process was seen
in approximately 0.5% of unselected outpatient
echocardiograms and appeared to be mechanistically
linked to restriction of anterior mitral leaﬂet motion,
such that the leaﬂet’s hinge becomes displaced
toward its free margin (51).
The risk of endocarditis in patients with MAC is
unknown. In a review of 80 patients with MAC, Ful-
kerson et al. (39) reported 3 cases of endocarditis
(4%). Endocarditis lesions included vegetation on the
mitral valve leaﬂets and, less commonly, on the
calciﬁed annulus, as well as paravalvular abscesses in
the region of MAC (53). Poor clinical outcomes and
increased mortality were associated with mitral
annulus lesions, rather than leaﬂet lesions. Limited
data also suggest high mortality (29%) among pa-
tients with MAC undergoing surgery for MR due to
infective endocarditis (54).
MAC AND ARRHYTHMIAS. Conduction system disease.
The association between MAC and conduction system
abnormalities was noted in the earliest reports of this
entity (2). Patients with MAC have higher prevalence
of atrioventricular block, bundle branch block, and
intraventricular conduction delay (2,39). Nair et al.
(40) examined 104 patients with MAC and compared
them with 121 matched control subjects. Conduction
defects were found to be prevalent in 70% of patients
with MAC versus 34% of control patients. The higher
incidence of conduction disease may be partially due
to direct extension of calciﬁc deposits to the region
of the atrioventricular node and the bundle of His
(55). Nonetheless, the prevalence of conduction dis-
turbances in patients with MAC, even among those
with MAC remote from the primary conduction sys-
tem (40), and the prevalence of remote conduction
disease (e.g., atrial conduction delay) (56) suggest
that diffuse degenerative conduction system disease
is frequently associated with MAC.
Atr ia l ﬁbr i l la t ion . Several large-scale, community-
based cohort studies observed a strong association
between the presence of MAC and AF. This associa-
tion is independent of baseline clinical risk factors for
AF and of the development of interim myocardial
infarction or heart failure (11,57). In a multivariable-
adjusted analysis of 1,126 patients from the cohort
of the Framingham Heart Study, MAC was associated
with an increased risk of AF (HR: 1.6; 95% CI: 1.1
to 2.2) (57). This association was further supported by
a recent large analysis of the ethnically diverse
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1939population of MESA. Among 6,641 participants, the
multivariable model revealed a strong and consistent
association between MAC and AF (HR: 1.9; 95% CI: 1.5
to 2.5) (11). The mechanisms by which MAC pre-
disposes to AF incidence are likely multifactorial, but
appear to be partially mediated through left atrial
enlargement (57). MAC might also interrupt the
interatrial and intra-atrial conduction processes,
leading to conduction system and atrial conduction
defects, thus resulting in AF (56).
MAC AND CARDIAC SURGERY/INTERVENTIONS. Severe
calciﬁcation of the mitral annulus can pose signiﬁcant
challenges to the surgeon undertaking mitral valve
replacement or repair. It is a contributing factor in
cardiac rupture at the atrioventricular junction, in
rupture of the LV free wall, and in injury to the
circumﬂex artery when debridement of MAC is per-
formed (10,16). Fusini et al. (29) found MAC to be
present among 24% of patients (99 of 410) referred for
mitral valve surgery. MAC was associated with
increased intraoperative conversion from valve repair
to replacement (8% of patients with MAC vs. 3% of
patients without MAC; p ¼ 0.04). In contrast, in a
series published by Chan et al. (58), MAC was present
in 19% of patients (119 of 625) referred for mitral valve
surgery and was not found to be a signiﬁcant risk
factor for conversion to mitral valve replacement.
A variety of surgical procedures have been pro-
posed to avoid the surgical complications mentioned
earlier. One approach is to perform mitral valve
replacement without annular calcium debridement,
securing the prosthetic valve inside the calciﬁed
annulus (10). This approach may be complicated by
periprosthetic leakage or by the inability to place an
adequately sized prosthetic valve without some
debridement. Another approach is to perform mitral
valve edge-to-edge repair without annulus recon-
struction; however, this can lead to unacceptable
mitral valve gradients post-procedure (59). The main
disadvantage of this technique is reduced durability,
resulting in an increased need for reoperation. The
preferred approach is complete decalciﬁcation and
reconstruction of the mitral annulus using methods
that have evolved from the treatment of annular ab-
scesses (10,16). In this approach, the calciﬁed annulus
is dissected, followed by reconstruction, which can be
achieved using annular suturing, an atrial ﬂap, or an
autologous pericardial patch (16). This technique is
preferably followed by mitral valve repair, if possible,
or by implantation of a prosthetic valve.
MAC also has clinical implications for rapidly
evolving transcatheter valve procedures. In pastyears, severe MAC has been frequently considered a
contraindication for percutaneous mitral repair (60).
Nonetheless, a recent small case series suggested that
percutaneous mitral repair with the MitraClip (Abbott
Vascular, Santa Clara, California) in the setting of se-
vere MAC is feasible, safe, and acceptably effective
(60). MAC was found to be an independent predictor
of permanent pacemaker implantation and of reduc-
tion in MR improvement following transcatheter
aortic valve replacement (61,62). Manipulation of
wires and large balloons during this procedure may
increase calcium debris, resulting in brain or coronary
emboli in patients with severe MAC, although this
association has not yet been properly evaluated. In
the future, transcatheter mitral valve replacement
may become a valuable alternative to mitral valve
surgery for patients with severe MR and a high
surgical risk (63). Among the many challenges faced
by the developers of these devices are lack of
complete, circumferential annular calciﬁcation, pre-
venting stable anchoring, and severe MAC, predis-
posing to annular rupture during valve deployment.
Experience with this technique has been mixed to
date, with some successes but a high rate of prosthesis
embolization.
CONCLUSIONS
Initially, MAC was considered a passive, degenera-
tive, age-related process, but there is now accumu-
lating evidence that it can also result from an active
atherosclerotic process. Other mechanisms, such as
increased mitral valve stress caused by aortic ste-
nosis or by hypertension and abnormal calcium-
phosphorus metabolism caused by CKD, may also
contribute to the development of MAC. There is
growing evidence that identiﬁcation of a calciﬁed
mitral annulus can also be related to a higher risk of
cardiovascular events, arrhythmias, mitral valve
disease, and mortality. Patients with MAC undergo-
ing conventional mitral valve surgery require proce-
dural modiﬁcations to attenuate periprocedural risk
of complications. Routine use of chest CT in the
work-up of all patients evaluated before cardiac
surgery or transcatheter valve interventions may
help elucidate the true incidence and clinical impli-
cations of MAC.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Raj R. Makkar, Cedars-Sinai Heart Institute, 127
South San Vicente Boulevard, AHSP, Suite A3600,
Los Angeles, California 90048. E-mail: Raj.Makkar@
cshs.org.
Abramowitz et al. J A C C V O L . 6 6 , N O . 1 7 , 2 0 1 5
Mitral Annulus Calciﬁcation O C T O B E R 2 7 , 2 0 1 5 : 1 9 3 4 – 4 1
1940RE F E RENCE S1. Korn D, Desanctis RW, Sell S. Massive calciﬁca-
tion of the mitral annulus. A clinicopathological
study of fourteen cases. N Engl J Med 1962;267:
900–9.
2. Nestico PF, Depace NL, Morganroth J, et al.
Mitral annular calciﬁcation: clinical, pathophysi-
ology, and echocardiographic review. Am Heart J
1984;107:989–96.
3. Fertman MH, Wolff L. Calciﬁcation of the mitral
valve. Am Heart J 1946;31:580–9.
4. Allison MA, Cheung P, Criqui MH, et al. Mitral
and aortic annular calciﬁcation are highly associ-
ated with systemic calciﬁed atherosclerosis. Cir-
culation 2006;113:861–6.
5. Kanjanauthai S, Nasir K, Katz R, et al. Re-
lationships of mitral annular calciﬁcation to car-
diovascular risk factors: the Multi-Ethnic Study of
Atherosclerosis (MESA). Atherosclerosis 2010;213:
558–62.
6. Asselbergs FW, Mozaffarian D, Katz R, et al.
Association of renal function with cardiac calci-
ﬁcations in older adults: the cardiovascular
health study. Nephrol Dial Transplant 2009;24:
834–40.
7. Foley PW, Hamaad A, El-Gendi H, et al. Inci-
dental cardiac ﬁndings on computed tomography
imaging of the thorax. BMC Res Notes 2010;3:326.
8. Johnson RC, Leopold JA, Loscalzo J. Vascular
calciﬁcation: pathobiological mechanisms and
clinical implications. Circ Res 2006;99:1044–59.
9. Fox CS, Vasan RS, Parise H, et al. Mitral annular
calciﬁcation predicts cardiovascular morbidity and
mortality: the Framingham Heart Study. Circula-
tion 2003;107:1492–6.
10. Okada Y. Surgical management of mitral
annular calciﬁcation. Gen Thorac Cardiovasc Surg
2013;61:619–25.
11. O’Neal WT, Eﬁrd JT, Nazarian S, et al. Mitral
annular calciﬁcation and incident atrial ﬁbrillation
in the Multi-Ethnic Study of Atherosclerosis.
Europace 2015;17:358–63.
12. Silbiger JJ, Bazaz R. Contemporary insights
into the functional anatomy of the mitral valve.
Am Heart J 2009;158:887–95.
13. Sell S, Scully RE. Aging changes in the
aortic and mitral valves. Histologic and histo-
chemical studies, with observations on the path-
ogenesis of calciﬁc aortic stenosis and calciﬁcation
of the mitral annulus. Am J Pathol 1965;46:
345–65.
14. Simon MA, Liu SF. Calciﬁcation of the mitral
valve annulus and its relation to functional valvular
disturbance. Am Heart J 1954;48:497–505.
15. Roberts WC, Perloff JK. Mitral valvular disease:
a clinicopathologic survey of the conditions
causing the mitral valve to function abnormally.
Ann Intern Med 1972;77:939–75.
16. Carpentier AF, Pellerin M, Fuzellier JF, et al.
Extensive calciﬁcation of the mitral valve anulus:
pathology and surgical management. J Thorac
Cardiovasc Surg 1996;111:718–29, discussion
729–30.17. Adler Y, Fink N, Spector D, et al. Mitral annulus
calciﬁcation—a window to diffuse atherosclerosis
of the vascular system. Atherosclerosis 2001;155:
1–8.
18. D’Cruz I, Panetta F, Cohen H, et al. Submitral
calciﬁcation or sclerosis in elderly patients: M
mode and two dimensional echocardiography in
“mitral anulus calciﬁcation.” Am J Cardiol 1979;44:
31–8.
19. Barasch E, Gottdiener JS, Larsen EKM, et al.
Clinical signiﬁcance of calciﬁcation of the ﬁbrous
skeleton of the heart and aortosclerosis in com-
munity dwelling elderly. The Cardiovascular
Health Study (CHS). Am Heart J 2006;151:39–47.
20. Kohsaka S, Jin Z, Rundek T, et al. Impact of
mitral annular calciﬁcation on cardiovascular events
in a multiethnic community: the Northern Man-
hattan Study. J Am Coll Cardiol Img 2008;1:617–23.
21. Eisen A, Tenenbaum A, Koren-Morag N, et al.
Calciﬁcation of the thoracic aorta as detected by
spiral computed tomography among stable angina
pectoris patients: association with cardiovascular
events and death. Circulation 2008;118:1328–34.
22. Higgins J, Mayo J, Skarsgard P. Cardiac
computed tomography facilitates operative plan-
ning in patients with mitral calciﬁcation. Ann
Thorac Surg 2013;95:e9–11.
23. Hamirani YS, Nasir K, Blumenthal RS, et al.
Relation of mitral annular calcium and coronary
calcium (from the Multi-Ethnic Study of Athero-
sclerosis [MESA]). Am J Cardiol 2011;107:1291–4.
24. Roberts WC. The senile cardiac calciﬁcation
syndrome. Am J Cardiol 1986;58:572–4.
25. Boon A, Cheriex E, Lodder J, et al. Cardiac
valve calciﬁcation: characteristics of patients with
calciﬁcation of the mitral annulus or aortic valve.
Heart 1997;78:472–4.
26. Silbiger JJ. Anatomy, mechanics, and patho-
physiology of the mitral annulus. Am Heart J 2012;
164:163–76.
27. Elmariah S, Delaney JAC, Bluemke DA, et al.
Associations of LV hypertrophy with prevalent and
incident valve calciﬁcation: Multi-Ethnic Study of
Atherosclerosis. J Am Coll Cardiol Img 2012;5:
781–8.
28. Newcomb AE, David TE, Lad VS, Bobiarski J,
Armstrong S, Maganti M. Mitral valve repair for
advanced myxomatous degeneration with poste-
rior displacement of the mitral annulus. J Thorac
Cardiovasc Surg 2008;136:1503–9.
29. Fusini L, Ghulam Ali S, Tamborini G, et al.
Prevalence of calciﬁcation of the mitral valve
annulus in patients undergoing surgical repair of
mitral valve prolapse. Am J Cardiol 2014;113:
1867–73.
30. Fox CS, Larson MG, Vasan RS, et al. Cross-
sectional association of kidney function with
valvular and annular calciﬁcation: the Framingham
heart study. J Am Soc Nephrol 2006;17:521–7.
31. Umana E, Ahmed W, Alpert MA. Valvular and
perivalvular abnormalities in end-stage renal dis-
ease. Am J Med Sci 2003;325:237–42.32. Correia J, Rodrigues D, da Silva AM, et al.
Massive calciﬁcation of the mitral valve annulus in
an adolescent with Marfan syndrome. A case
report. Rev Port Cardiol 2006;25:921–6.
33. Radke RM, Baumgartner H. Diagnosis and
treatment of Marfan syndrome: an update. Heart
2014;100:1382–91.
34. Schieken RM, Kerber RE, Ionasescu VV, et al.
Cardiac manifestations of the mucopolysacchar-
idoses. Circulation 1975;52:700–5.
35. Elmariah S, Budoff MJ, Delaney JAC, et al. Risk
factors associated with the incidence and pro-
gression of mitral annulus calciﬁcation: the Multi-
Ethnic Study of Atherosclerosis. Am Heart J 2013;
166:904–12.
36. Roberts WC. Morphologic features of the
normal and abnormal mitral valve. Am J Cardiol
1983;51:1005–28.
37. Sugihara N, Matsuzaki M. The inﬂuence of se-
vere bone loss on mitral annular calciﬁcation in
postmenopausal osteoporosis of elderly Japanese
women. Jpn Circ J 1993;57:14–26.
38. Movahed MR, Saito Y, Ahmadi-Kashani M,
et al. Mitral annulus calciﬁcation is associated with
valvular and cardiac structural abnormalities.
Cardiovasc Ultrasound 2007;5:14.
39. Fulkerson PK, Beaver BM, Auseon JC, et al.
Calciﬁcation of the mitral annulus: etiology, clin-
ical associations, complications and therapy. Am J
Med 1979;66:967–77.
40. Nair CK, Runco V, Everson GT, et al. Conduc-
tion defects and mitral annulus calciﬁcation. Br
Heart J 1980;44:162–7.
41. Völzke H, Haring R, Lorbeer R, et al. Heart valve
sclerosis predicts all-cause and cardiovascular
mortality. Atherosclerosis 2010;209:606–10.
42. Gondrie MJA, van der Graaf Y, Jacobs PC,
et al., for the PROVIDI Study Group. The associa-
tion of incidentally detected heart valve calciﬁ-
cation with future cardiovascular events. Eur
Radiol 2011;21:963–73.
43. Ramaraj R, Manrique C, Hashemzadeh M, et al.
Mitral annulus calciﬁcation is independently
associated with all-cause mortality. Exp Clin Car-
diol 2013;18:e5–7.
44. Atar S, Jeon DS, Luo H, et al. Mitral annular
calciﬁcation: a marker of severe coronary artery
disease in patients under 65 years old. Heart
2003;89:161–4.
45. Gardin JM, McClelland R, Kitzman D, et al. M-
mode echocardiographic predictors of six- to
seven-year incidence of coronary heart disease,
stroke, congestive heart failure, and mortality in
an elderly cohort (the Cardiovascular Health
Study). Am J Cardiol 2001;87:1051–7.
46. Boon A, Lodder J, Cheriex E, et al. Mitral
annulus calciﬁcation is not an independent risk
factor for stroke: a cohort study of 657 patients.
J Neurol 1997;244:535–41.
47. Benjamin EJ, Plehn JF, D’Agostino RB, et al.
Mitral annular calciﬁcation and the risk of stroke
in an elderly cohort. N Engl J Med 1992;327:
374–9.
J A C C V O L . 6 6 , N O . 1 7 , 2 0 1 5 Abramowitz et al.
O C T O B E R 2 7 , 2 0 1 5 : 1 9 3 4 – 4 1 Mitral Annulus Calciﬁcation
194148. Kizer JR, Wiebers DO, Whisnant JP, et al.
Mitral annular calciﬁcation, aortic valve sclerosis,
and incident stroke in adults free of clinical car-
diovascular disease: the Strong Heart Study.
Stroke 2005;36:2533–7.
49. Rodriguez CJ, Bartz TM, Longstreth WT Jr.,
et al. Association of annular calciﬁcation and aortic
valve sclerosis with brain ﬁndings on magnetic
resonance imaging in community dwelling older
adults: the Cardiovascular Health Study. J Am Coll
Cardiol 2011;57:2172–80.
50. Willens HJ, Ferreira AC, Gallagher AJ, et al.
Mobile components associated with rapidly
developing mitral annulus calciﬁcation in patients
with chronic renal failure: review of mobile ele-
ments associated with mitral annulus calciﬁcation.
Echocardiography 2003;20:363–7.
51. Muddassir SM, Pressman GS. Mitral annular
calciﬁcation as a cause of mitral valve gradients.
Int J Cardiol 2007;123:58–62.
52. Labovitz AJ, Nelson JG, Windhorst DM, et al.
Frequency of mitral valve dysfunction from mitral
anular calcium as detected by Doppler echocardi-
ography. Am J Cardiol 1985;55:133–7.
53. Eicher JC, De Nadai L, Soto FX, et al. Bacterial
endocarditis complicating mitral annular calciﬁca-
tion: a clinical and echocardiographic study.
J Heart Valve Dis 2004;13:217–27.54. Vistarini N, d’Alessandro C, Aubert S, et al.
Surgery for infective endocarditis on mitral annulus
calciﬁcation. J Heart Valve Dis 2007;16:611–6.
55. Takamoto T, Popp RL. Conduction distur-
bances related to the site and severity of mitral
anular calciﬁcation: a 2-dimensional echocardio-
graphic and electrocardiographic correlative
study. Am J Cardiol 1983;51:1644–9.
56. Pekdemir H, Cansel M, Yagmur J, et al.
Assessment of atrial conduction time by tissue
Doppler echocardiography and P-wave dispersion
in patients with mitral annulus calciﬁcation.
J Electrocardiol 2010;43:339–43.
57. Fox CS, Parise H, Vasan RS, et al. Mitral
annular calciﬁcation is a predictor for incident
atrial ﬁbrillation. Atherosclerosis 2004;173:291–4.
58. Chan V, Ruel M, Hynes M, et al. Impact of
mitral annular calciﬁcation on early and late out-
comes following mitral valve repair of myxoma-
tous degeneration. Interact Cardiovasc Thorac
Surg 2013;17:120–5.
59. Maisano F, Caldarola A, Blasio A, et al.
Midterm results of edge-to-edge mitral valve
repair without annuloplasty. J Thorac Cardiovasc
Surg 2003;126:1987–97.
60. Buzzatti N. Percutaneous mitral repair in the
setting of severe mitral annular calciﬁcation:midterm results from a single centre experience.
Paper presented at: EuroPCR 2015; May 20, 2015;
Paris, France.
61. Boerlage-Van Dijk K, Kooiman KM,
Yong ZY, et al. Predictors and permanency of
cardiac conduction disorders and necessity of
pacing after transcatheter aortic valve implan-
tation. Pacing Clin Electrophysiol 2014;37:
1520–9.
62. Durst R, Avelar E, McCarty D, et al. Outcome
and improvement predictors of mitral regurgita-
tion after transcatheter aortic valve implantation.
J Heart Valve Dis 2011;20:272–81.
63. De Backer O, Piazza N, Banai S, et al. Percu-
taneous transcatheter mitral valve replacement:
an overview of devices in preclinical and early
clinical evaluation. Circ Cardiovasc Interv 2014;7:
400–9.KEY WORDS calciﬁed, cardiovascular
diseases, mitral annular calciﬁcation,
mitral valve, valvular calciﬁcationAPPENDIX For a further description of the
pathogenesis and associations of MAC, please
see the online version of this article.
